Literature DB >> 15017020

Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans.

Speranza Rubattu1, Rosita Stanzione, Emanuele Di Angelantonio, Bastianina Zanda, Anna Evangelista, David Tarasi, Bruna Gigante, Angelo Pirisi, Ercole Brunetti, Massimo Volpe.   

Abstract

BACKGROUND AND
PURPOSE: A precise definition of genetic factors responsible for common forms of stroke is still lacking. The purpose of the present study was to investigate the contributory role of the genes encoding atrial natriuretic peptide (ANP) and type A natriuretic peptide receptor (NPRA) in humans' susceptibility to develop ischemic stroke.
METHODS: Allele and genotype frequencies of ANP and NPRA were characterized in an Italian case-control study with patients affected by vascular disease or risk factors. Subjects were recruited from the island of Sardinia (206 cases, 236 controls).
RESULTS: A significant association between the ANP/TC2238 polymorphic site and stroke occurrence was found when a recessive model of inheritance was assumed. The risk conferred by this mutant genotype, when estimated by multivariate logistic regression analysis, was 3.8 (95% confidence interval, 1.4 to 10.9). A significantly increased risk of stroke recurrence was observed among cases carrying the ANP/CC2238 genotype compared with cases carrying the ANP/TT2238 genotype (P=0.04). No direct association of NPRA with stroke occurrence was detected. However, a significant epistatic interaction between the ANP/CC2238 genotype and an allelic variant of NPRA led to a 5.5-fold increased risk of stroke (95% confidence interval, 1.5 to 19.4).
CONCLUSIONS: Our findings support a direct contributory role of ANP to stroke in humans. A significant interaction between ANP and NPRA on stroke occurrence was found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017020     DOI: 10.1161/01.STR.0000119381.52589.AB

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Potential association between frequent nonsynonymous variant of NPPA and cardioembolic stroke.

Authors:  Jeong-Hyun Kim; Bo-Hyung Jang; Ho Yeon Go; Sunju Park; Yong-Cheol Shin; Sung-Hoon Kim; Seong-Gyu Ko
Journal:  DNA Cell Biol       Date:  2012-03-08       Impact factor: 3.311

2.  Human-specific nonsense mutations identified by genome sequence comparisons.

Authors:  Yoonsoo Hahn; Byungkook Lee
Journal:  Hum Genet       Date:  2006-02-10       Impact factor: 4.132

3.  Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.

Authors:  George V Z Dedoussis; Sandy Maumus; John Skoumas; Despoina M Choumerianou; Christos Pitsavos; Christodoulos Stefanadis; Sophie Visvikis-Siest
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 4.  Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Authors:  Massimo Volpe; Speranza Rubattu; John Burnett
Journal:  Eur Heart J       Date:  2013-11-13       Impact factor: 29.983

5.  N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Reena Gupta; Beeya Na; Alan H B Wu; Nelson B Schiller; Mary A Whooley
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

6.  Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.

Authors:  Zhijun Wu; Min Xu; Haihui Sheng; Yuqing Lou; Xiuxiu Su; Yanjia Chen; Lin Lu; Yan Liu; Wei Jin
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 7.  Natriuretic Peptides and Cardiometabolic Health.

Authors:  Deepak K Gupta; Thomas J Wang
Journal:  Circ J       Date:  2015-06-23       Impact factor: 2.993

8.  Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.

Authors:  Valentina Cannone; Brenda K Huntley; Timothy M Olson; Denise M Heublein; Christopher G Scott; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

Review 9.  A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae.

Authors:  Amy I Lynch; Steven A Claas; Donna K Arnett
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 10.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.